Purchase Order 75H70926P00021
- Not listed
- The Indian Health Service (IHS) awarded a $45,900 firm fixed-price purchase order to Cepheid Inc. on December 1, 2025, for molecular diagnostic solutions with a completion date of November 30, 2030. The contract, which carries no set-aside designation, will be performed in Tohatchi, New Mexico. Cepheid, a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, will deliver diagnostic testing capabilities to support IHS healthcare operations. The company...
- The Indian Health Service (IHS) has awarded a $28.3K purchase order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with a performance deadline of December 10, 2030. This firm fixed-price contract, designated as the FPSU CEPHEID SERVICE AGREEMENT BASE +4, contains no set-aside provisions and will be performed in Poplar, Montana. The award follows Cepheid's established track record of providing advanced diagnostic systems and testing solutions to...
- The Indian Health Service awarded a purchase order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on October 16, 2025. The contract, valued at $260,025, runs from October 19, 2025, through October 18, 2026, with an ultimate completion date of October 18, 2030. Utilizing firm fixed-price pricing with no set-aside designation, this purchase order will be performed in Parker, Arizona, and represents one of five related contract actions awarded under...
- The Indian Health Service awarded a purchase order to Cepheid Inc. for clinical laboratory supplies with a ceiling value of $679,320 under a firm fixed-price contract. The award, announced on May 15, 2024, covers a performance period from January 1, 2024 through December 31, 2024, with an ultimate completion date of May 14, 2025. This contract modification represents a closeout action and includes no set-aside designation. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale,...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a delivery order valued at $242,163.20 by the Indian Health Service (IHS) for Option Year Two of a contract covering laboratory supplies and testing services. The award, issued on July 2, 2024, covers the period from September 1, 2024, through August 31, 2025, with an ultimate completion date of August 31, 2028. The contract utilizes a firm fixed-price pricing model with no set-aside designation and is...
- The Indian Health Service awarded a firm fixed-price delivery order to Cepheid Inc. valued at $323,496 for the period July 1, 2025 through June 30, 2026. This task order, which carries no set-aside designation, will be performed in Red Lake, Minnesota. As a leading manufacturer of molecular diagnostic solutions, Cepheid will deliver diagnostic equipment, reagents, and associated services to support clinical testing capabilities at the IHS facility, consistent with the company's established...
- The U.S. Indian Health Service awarded a $168,475.00 firm fixed-price purchase order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is for the administrative modification to extend the period of performance to December 31, 2025. Cepheid provides comprehensive molecular diagnostic technologies to various federal agencies, including the Department of Veterans Affairs (VA), Indian Health Service (IHS), and Defense...
- This is a firm fixed-price delivery order contract awarded by the Indian Health Service (IHS), a civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract is valued at $176,833.92 and covers the period from July 1, 2025, to June 30, 2026. Cepheid will provide the IHS with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
- The Indian Health Service awarded a purchase order to Cepheid Inc. on February 8, 2024, for laboratory supplies and testing materials to support operations at the Chinle, Arizona facility. The contract encompasses consumable items for use with Cepheid GeneXpert analyzer systems, including microbiology supplies, reagent kits, and COVID-19 test kits, ordered on an as-needed basis through March 31, 2026. The contract carries a ceiling value of $1.49M and employs firm fixed-price pricing with no...
- The Indian Health Service awarded a $187,000 firm fixed-price Blanket Purchase Agreement (BPA) call to Cepheid, a molecular diagnostic solutions manufacturer based in Sunnyvale, California, for reagents and supplies. The contract, which was ultimately completed and closed out on February 7, 2024, approximately one year after its February 8, 2023 award date, involved no set-aside designation. This award represents a continuation of Cepheid's ongoing relationship with federal healthcare...
The Indian Health Service awarded a $48,005 firm fixed-price purchase order to Cepheid Inc. for molecular diagnostic services under the CSU-Cepheid Service Agreement, with performance at Crow Agency, Montana. The contract, awarded on December 29, 2025, carries a ceiling value of $180,025 and extends through December 31, 2030, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced molecular diagnostic systems, will provide diagnostic testing solutions and related services to support IHS healthcare delivery at the tribal health facility. This award reflects Cepheid's established role as a key supplier of molecular diagnostic technologies across the federal healthcare system. The company's GeneXpert diagnostic systems and associated test kits address critical clinical testing needs, including detection of infectious diseases such as COVID-19, influenza, and other pathogens. The contract supports IHS's mission to deliver healthcare services to American Indian and Alaska Native populations, leveraging Cepheid's proven capabilities in providing diagnostic equipment, reagents, and maintenance services that have been successfully deployed across multiple federal agencies including the Department of Veterans Affairs and Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.0k | 12/29/25 |